A novel Lyn-binding peptide inhibitor blocks eosinophil differentiation, survival, and airway eosinophilic inflammation

Journal of Immunology

Volumn 163, Issue 2, 1999, Pages 939-946

  Adachi, Tetsuya ^a   Stafford, Susan ^a   Sur, Sanjiv ^a   Alam, Rafeul ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE; PHOSPHOTRANSFERASE; RECEPTOR BLOCKING AGENT; RECEPTOR SUBUNIT;

ANIMAL MODEL; ARTICLE; ASTHMA; BINDING SITE; CELL DIFFERENTIATION; CELL SURVIVAL; DEGRANULATION; ENZYME ACTIVATION; EOSINOPHIL; HISTAMINE RELEASE; INFLAMMATION; INTERNALIZATION; LYMPHOCYTE MIGRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; ASTHMA; BINDING, COMPETITIVE; BLOOD PROTEINS; BONE MARROW CELLS; BRONCHI; CELL DIFFERENTIATION; CELL SURVIVAL; CELLS, CULTURED; CYTOKINE RECEPTOR COMMON BETA SUBUNIT; ENZYME ACTIVATION; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILS; GROWTH INHIBITORS; HUMANS; INTERLEUKIN-5; JANUS KINASE 2; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; PEPTIDES; PROTEIN BINDING; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTORS, CELL SURFACE; RECEPTORS, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; RECEPTORS, INTERLEUKIN-3; RIBONUCLEASES; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; STEARIC ACIDS;

EID: 0033565287     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Gleich, G. J. 1990. The eosinophil and bronchial asthma: current understanding. J. Allergy Clin. Immunol. 85:422.
2. Yamaguchi, Y., T. Suda, J. Suda, M. Eguchi, Y. Miura, N. Harada, A. Tominaga, and K. Takatsu. 1988. Purified interleukin-5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med. 167:43.
3. Yamaguchi, Y., T. Sudo, S. Ohta, K. Tominaga, Y. Miura, and T. Kasahara. 1991. Analysis of the survival of mature eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood 78:2542.
4. Yamaguchi, Y., Y. Hayashi, Y. Sugama, Y. Miura, T. Kasahara, S. Kitamura, M. Torisu, S. Mita, A. Tominaga, and K. Takatsu. 1988. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival: IL-5 as an eosinophil chemotactic factor. J. Exp. Med. 167:1732.
5. Wang, J. M., A. Rambaldi, A. Biondi, Z. G. Chen, C. J. Sanderson, and A. Mantovani. 1989. Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur. J. Immunol. 19:701.
6. Fujisawa, T., R. I. Abu-Ghazaleh, H. Kita, C. J. Sanderson, and G. J. Gleich. 1990. Regulatory effect of cytokines on eosinophil degranulation. J. Immunol. 144:642.
7. Horie, S., G. J. Gleich, and H. Kita. 1996. Cytokines directly induce degranulation and superoxide production from human eosinophils. J. Allergy Clin. Immunol. 98:371.
8. Walsh, G. M., A. Hartnell, A. J. Wardlaw, K. Kurihara, C. J. Sanderson, and A. B. Kay. 1990. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leukocyte integrin (CD11/18)-dependent manner. Immunology 71:258.
9. Nakajima, H., G. J. Gleich, and H. Kita. 1996. Constitutive production of IL-4 and IL-10 and stimulated production of IL-8 by normal peripheral blood eosinophils. J. Immunol. 156:4859.
10. Takafuji, S., S. C. Bischoff, A. L. De Weck, and C. A. Dahinden. 1991. IL-3 and IL-5 prime normal human eosinophils to produce leukotriene C4 in response to soluble agonists. J. Immunol. 147:3855.
11. Rothenberg, M. E., J. Petersen, R. L. Stevens, D. S. Silberstein, D. T. McKenzie, K. F. Austen, and W. F. Owen. 1989. IL-5-dependent conversion of normodense human eosinophils to the hypodense phenotype uses 3T3 fibroblasts for enhanced viability, accelerated hypodensity, and sustained antibody-dependent cytotoxicity. J. Immunol. 143:2311.
12. Hamelmann, E., A. Oshiba, J. Loader, G. L. Larsen, G. Gleich, J. Lee, and E. W. Gelfand. 1997. Antiinterleukin-5 antibody prevents airway hyperresponsiveness in a murine model of airway sensitization. Am. J. Respir. Crit. Care Med. 155:819.
13. Foster, P. S., S. P. Hogan, A. J. Ramsay, K. I. Matthaei, and I. G. Young. 1996. IL-5 deficiency abolishes eosinophilia, airway hyperreactivity, and lung damage in a mouse model of asthma. J. Exp. Med. 183:195.
14. Pazdrak, K., D. Schreiber, P. Forsythe, L. Justement, and R. Alam. 1995. The signal transduction mechanism of IL-5 in eosinophils: the involvement of lyn tyrosine kinase and the ras-raf 1-MEK-MAP kinase pathway. J. Exp. Med. 181: 1827.
15. Pazdrak, K., S. Stafford, and R. Alam. 1995. The activation of the Jak-STAT1 signaling pathway by IL-5 in eosinophils. J. Immunol. 155:397.
16. van der Bruggen, T., E. Caldenhoven, D. Kanters, P. Coffer, J. A. Raaijmakers, J. W. Lammers, and L. Koenderman. 1995. Interleukin-5 signaling in human eosinophils involves JAK2 tyrosine kinase and STAT1a. Blood 85:1442.
17. Yousefi, S., D. C. Hoessli, K. Blaser, G. B. Mills, and H. U. Simon. 1996. Requirement of Lyn and Syk tyrosine kinases for the prevention of apoptosis by cytokine in human eosinophils. J. Exp. Med. 183:1407.
18. Pazdrak, K., B. Olszewska-Pazdrak, S. Stafford, R. Garofalo, and R. Alam. 1998. Lyn, Jak2, and Raf-1 kinases are critical for the anti-apoptotic effect of interleukin 5, whereas only Raf-1 kinase is essential for eosinophil activation and degranulation. J. Exp. Med. 188:421.
19. Simon, H. U., S. Yousefi, B. Dibbert, F. Levi-Schaffer, and K. Blaser. 1997. Anti-apoptotic signals of granulocyte-macrophage colony-stimulating factor are transduced via Jak2 tyrosine kinase in eosinophils. Eur. J. Immunol. 27:3536.
20. Adachi, T., K. Pazdrak, S. Stafford, and R. Alam. 1999. The mapping of the Lyn kinase-binding site of the common β (βc) subunit of IL-3/GM-CSF/IL-5 receptor. J. Immunol. 162:1496.
21. Sankaram, M. B. 1994. Membrane interaction of small N-myristoylated peptides: implications for membrane anchoring and protein-protein association. Biophys. J. 67:105.
22. Eicholtz, T., D. B. A. de Bont, J. de Widt, R. M. J. Liskamp, and H. L. Ploegh. 1993. A myristoylated pseudosubstrate peptide, a novel protein kinase C inhibitor. J. Biol. Chem. 268:1982.
23. Hansel, T. T., I. J. M. de Vries, T. Iff, S. Rihs, M. Wandzilak, S. Betz, K. Blaser, and C. Walker. 1991. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J. Immunol. Methods. 145:105.
24. Alam, R., P. A. Forsythe, M. A. Lett-Brown, and J. A. Grant. 1989. Cellular origin of histamine-releasing factor produced by peripheral blood. J. Immunol. 142:3951.
25. Takamoto, M., and K. Sugane. 1995. Synergism of IL-3, IL-5, and GM-CSF on eosinophil differentiation and its application for an assay of murine IL-5 as an eosinophil differentiation factor. Immunol. Lett. 45:43.
26. Stafford, S., H. Li, P. A. Forsythe, M. Ryan, R. Bravo, and R. Alam. 1997. Monocyte chemotactic protein-3 (MCP-3)/fibroblast-induced cytokine (FIC) in eosinophilic inflammation of the airways and the inhibitory effects of an anti-MCP-3/FIC antibody. J. Immunol. 158:4953.
27. Miyajima, A., A. L. F. Mui, T. Ogorochi, and K. Sakamaki. 1993. Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 82:1960.
28. Jouvin, M. H., M. Adamczewski, R. Numerof, O. Letourneur, A. Valle, and J.-P. Kinet. 1994. Differential control of the tyrosine kinases Lyn and Syk by the two signaling chains of the high affinity immunoglobulin E receptor. J. Biol. Chem. 269:5918.
29. Kihara, H., and R. P. Siraganian. 1994. Src homology 2 domains of Syk and Lyn bind to tyrosine-phosphorylated subunits of the high affinity IgE receptor. J. Biol. Chem. 269:22427.
30. Yamanashi, Y., T. Kakiuchi, J. Mizuguchi, T. Yamamoto, and K. Toyoshima. 1991. Association of B cell antigen receptor with protein tyrosine kinase Lyn. Science 251:192.
31. fyn domains associate with non-phosphorylated and phosphorylated Ig-α. Proc. Natl. Acad. Sci. USA 91:4268.
32. Vonakis, B. M., H. Chen, H. Haleem-Smith, and H. Metzger. 1997. The unique domain as the site on Lyn kinase for its constitutive association with the high affinity receptor for IgE. J. Biol. Chem. 272:24072.
33. Ferrero, E., C.-L. Hsieh, U. Francke, and S. M. Goyert. 1990. CD14 is a member of the family of leucine-rich proteins and is encoded by a gene syntenic with multiple receptor genes. J. Immunol. 145:331.
34. Stamenkovic, I., and B. Seed. 1988. CD19, the earliest differentiation antigen of the B cell lineage, bears three extracellular Ig-like domains and an Epstein-Barr virus-related cytoplasmic tail. J. Exp. Med. 168:1205.
35. lyn kinase, and phosphalidylinositol-3 kinase in signal transduction via the human B lymphocyte antigen CD22. Eur. J. Immunol. 26:1246.
36. Hibbs, M. L., D. M. Tarlinton, J. Armes, D. Grail, G. Hodgson, R. Maglitto, S. A. Stacker, and A. R. Dunn. 1995. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83:301.
37. Nishizumi, H., I. Taniuchi, Y. Yamanashi, D. Kitamura, D. Ilic, S. Mori, T. Watanabe, and T. Yamamoto. 1995. Impaired proliferation of peripheral B cells and identification of autoimmune disease in lyn-deficient mice. Immunity 3:549.
38. Wang, J., T. Koizumi, and T. Watanabe. 1996. Altered antigen receptor signaling and impaired Fas-mediated apoptosis of B cells in Lyn-deficient mice. J. Exp. Med. 184:831.
39. Chan, V. W. F., F. Meng, P. Soriano, A. L. DeFranco, and C. A. Lowell. 1997. Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation. Immunity 7:69.
40. Dombrowicz, D., S. Lin, V. Flamand, A. T. Brini, B. H. Koller, and J. P. Kinet. 1998. Allergy-associated FcRβ is a molecular amplifier of IgE- and IgG-mediated in vivo response. Immunity 8:517.
41. Nishinakamura, R., A. Miyajima, P. J. Mee, V. L. J. Tybulewicz, and R. Murray. 1996. Hematopoiesis in mice lacking the entire granulocyte-macrophage colony-stimulating factor/interleukin-3/interleukin-5 functions. Blood 88:2458.
42. Collins, P. D., S. Marleau, D. A. Griffiths-Johnson, P. J. Jose, and T. J. Williams. 1995. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 182:1169.
43. Mould, A. W., K. I. Matthaei, I. G. Young, and P. S. Foster. 1997. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J. Clin. Invest. 99:1064.